The Library
Access to targeted therapies in renal cell cancer
Tools
Jones, Robert and De Santis, Maria (2013) Access to targeted therapies in renal cell cancer. Seminars in Oncology, Volume 40 (Number 4). pp. 521-528. doi:10.1053/j.seminoncol.2013.05.012 ISSN 0093-7754.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1053/j.seminoncol.2013.05.012
Abstract
There is limited access to targeted therapies for renal cancer in many parts of the western world. This is driven by reimbursement rather than regulatory issues. Indeed, only a small fraction of the global population benefits from unlimited reimbursement of targeted therapies. Dedicated bodies, such as the UK National Institute for Clinical Excellence, assess agents on their cost-effectiveness as well as their efficacy. The results have been disappointing for patients, with the majority of agents being rejected for reimbursement. Despite this trend, there is a general appetite to address cost and value in many part of the world. This article gives a current overview of this rapidly changing field.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Cancer Research Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Seminars in Oncology | ||||
Publisher: | W.B. Saunders Co. | ||||
ISSN: | 0093-7754 | ||||
Official Date: | August 2013 | ||||
Dates: |
|
||||
Volume: | Volume 40 | ||||
Number: | Number 4 | ||||
Page Range: | pp. 521-528 | ||||
DOI: | 10.1053/j.seminoncol.2013.05.012 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |